newsfilter
← Latest News
PR Newswire·

Researchers Confirm Thymosin Beta 4's Ability to Protect Eyes From Ethanol Injury

ROCKVILLE, Md., Jan. 25, 2022 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB:RGRX) ("RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair, and regeneration), today announced that Chinese researchers confir